Advertisement

Topics

Celera Genomics Company Profile

19:38 EST 14th December 2018 | BioPortfolio

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera businesses are its online information business and its therapeutics discovery business. The online information business is a leading provider of genomic and related biological and medical information. Pharmaceutical, biotechnology, and academic customers use this information, along with customized information technology solutions provided by Celera, to enhance their capabilities in the fields of life science research and pharmaceutical and diagnostic discovery and development. Celera recently expanded its focus to include therapeutic discovery and development. Celera intends to leverage its capabilities in genomics, proteomics, and bioinformatics, both in internal programs and through collaborations, to identify drug targets and diagnostic markers, and to discover and develop novel therapeutic candidates. Initially, Celera intends to focus its therapeutic discovery efforts in the field of oncology. In June 2001, Celera announced the signing of a definitive merger agreement with Axys, a small molecule drug discovery and development company. Celera believes that Axys’ medicinal and structural chemistry and biology capabilities will accelerate the development of its therapeutic discovery business. Celera is also participating in the commercialization of diagnostic products based on its discoveries through Celera Diagnostics, a recently announced joint venture with Applied Biosystems.

Location

45 West Gude Drive
Rockville
MD
20850
United States of America

Contact

Phone: +1 240 453 3000
Fax: +1 240 453 4000
Email: robert.bennett@celera.com


News Articles [417 Associated News Articles listed on BioPortfolio]

Congratulations to veteran genomics editor @bjasny on her retirement from @sciencemagazine. She famously handled the Celera/HGP saga in 2000-01 and discussed some of the key issues here: https://epjdatascience.springeropen.com/articles/10.1140/epjds13 

Congratulations to veteran genomics editor @bjasny on her retirement from @sciencemagazine. She famously handled the Celera/HGP saga in 2000-01 and discussed some of the key issues here: https://e...

M&As this week: 10x Genomics, Atlantic Research Group, AGC

10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain...Read More... The post M&As this week: 10x Genomics, A...

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

QUANTUM GENOMICS: Quantum Genomics to Host Key Opinion Leader and Investor Event on December 10, 2018

Event Focused on Phase IIb Arterial Hypertension Data opening the way to a pivotal Phase 3 Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in th...

#jobs #lifescience CK Group: Genomics Manufacturing Technician – Hertfordshire

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: CK Group: Genomics Manufacturing Technician – Hertfordshire . £18,000:...

Drugs and Medications [0 Results]

None

PubMed Articles [207 Associated PubMed Articles listed on BioPortfolio]

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

The growing availability of genomic information to the public may spur discussion about genetics and genomics on social media. Sites, including Twitter, provide a unique space for the public to access...

Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.

The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.

Guidelines recommend patients be informed of their incidental results (IR) when undergoing genomic sequencing (GS), yet there are limited tools to support patients' decisions about learning IR. The ai...

Clinical Trials [94 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

GENetic Education Risk Assessment and TEsting Study

The goal of the GENERATE study is to improve genetic testing and cancer prevention in family members of pancreatic cancer patients with identified genetic mutations (inherited changes). Th...

Companies [418 Associated Companies listed on BioPortfolio]

PE Corporation-Celera Genomics

The Celera Genomics Group is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborat...

Celera Genomics

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera ...

Celera Corporation

Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary ...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

MetaMorphix, Inc.

MetaMorphix Inc. was formed in 1994 as a research collaboration between Genetics Institute, now a part of Wyeth (a pharmaceutical company) and the Johns Hopkins School of Medicine. The purpose of the ...

More Information about "Celera Genomics" on BioPortfolio

We have published hundreds of Celera Genomics news stories on BioPortfolio along with dozens of Celera Genomics Clinical Trials and PubMed Articles about Celera Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celera Genomics Companies in our database. You can also find out about relevant Celera Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record